• NIA Innovations & COVID-19
  • Newsletter Sign-Up
  • FAQs
  • Case Studies
  • Contact Us
NIANIANIANIA
  • About
    • What the NIA offers
    • Selection Process
    • Core Team
    • Mentors
    • Partners
    • Collaborate
    • Apply
  • Fellows and Innovations
    • Overview
    • Fellows
    • Innovations
    • Alumni
  • Latest
    • Events
    • News & blogs

The Trexit initiative: transperineal prostate biopsies under local anaesthetic

    Home News The Trexit initiative: transperineal prostate biopsies under local anaesthetic
    NextPrevious

    The Trexit initiative: transperineal prostate biopsies under local anaesthetic

    By admin | News | Comments are Closed | 2 April, 2019 | 0

    A new, safer and more comfortable biopsy technique for detecting prostate cancer has been rolled-out to hospitals across south-east London.

    The Precision Point transperineal biopsy, introduced by NHS Innovation Accelerator Fellow Rick Popert, Consultant Urologist at Guy’s and St Thomas’ NHS FT (GSTT), replaces the transrectal biopsy – proving faster diagnosis and reducing discomfort for patients.

    There are around 40,000 new prostate cancer diagnoses each year in the UK, with two types of biopsies – the transrectal and the transperineal – used to detect abnormal cells and determine the severity of the condition.

    The transrectal biopsy has a greater risk of severe infection and the transperineal biopsy is considered to be better, safer and more comprehensive. However, the transperineal biopsy has previously required a general anaesthetic – resulting in delays to the patient pathway. Mr Popert’s new precision-point transperineal technique allows comprehensive and targeted biopsies using just two single skin punctures, delivered under local anaesthetic.

    The technique was first adopted by GSTT in September 2017, replacing the transrectal biopsies. The intention was to roll out the new technique across the network by 29th March 2019 – a plan dubbed ‘Trexit’ due to its coinciding with the UK’s intended departure from the European Union.

    While Brexit has been postponed, Trexit has been implemented ahead of schedule, with full network coverage achieved on 7th March.

    Key to this achievement is the work of Advanced Nurse Practitioner, Jonah Rusere, who has been travelling across the south-east London network, setting up local anaesthetic transperineal biopsy services.

    Having successfully rolled-out the new technique in south-east London, the team now hopes to extend the initiative across the NHS. The ultimate aim is to make the NHS the first health system in the world to abandon transrectal prostate biopsies.

    Case study: spread to Lewisham and Greenwich NHS Trust

    Lewisham and Greenwich NHS Trust has completely phased out the standard transrectal prostate biopsy and replaced it with the gold standard transperineal biopsy.

    Mr Mohamed Hammadeh, Consultant Urology Surgeon and Clinical Director of Urology, said:

    “It is wonderful that we can offer patients this service. This is a more accurate way of testing for cancer than the standard transrectal biopsies, which we have phased out. We can now offer biopsies under local or sedation anaesthesia, depending on the patient’s preference.”

    “This development is thanks to great work from our staff, our management team in the surgery division, our partners in the South East London Cancer Network, and the urology department at Guys and St Thomas’ NHS Foundation Trust, who provided training for our staff.”

    More information about the Precision Point transperineal biopsy is available here.

    No tags.

    Related Posts

    • The new palliative care gold standard

      By admin | Comments are Closed

      By: Julia Riley The EIU’s recent Quality of Death report praised palliative care in the UK as the best in the world, citing the quality and availability of services provided by the NHS and hospice movement as “second toRead more

    • Nervecentre Software win prestigious Building Better Healthcare Award

      By admin | Comments are Closed

      Nervecentre Software in partnership with Nottingham University Hospitals NHS Trust have won the prestigious award for ‘Best Communications and IT product’ at the Building Better Healthcare Awards, held on 4th November 2015, The award isRead more

    • Southend University Hospital NHS Foundation Trust live with Nervecentre electronic observations

      By admin | Comments are Closed

      Southend University Hospital NHS Foundation Trust has now deployed Nervecentre Electronic Observations software using mobiles devices across the hospitals to improve patient safety and communications. Funded through the Nursing Technology Fund, Electronic Observations are now liveRead more

    • Nervecentre in Australia… Success at the ISRRS Symposium in Melbourne


      By admin | Comments are Closed

      Written by Jim Trueman Attendees of the symposium held by the International Society for Rapid Response Systems and Medical Emergency Teams are all clinicians that intuitively recognise the problems that Nervecentre was designed to solve. Read more

    • i-THRIVE: Manchester and Salford’s Integrated Access and Care Pathways 


      By admin | Comments are Closed

      What was the problem you were trying to solve? Central Manchester University Hospitals NHS Foundation Trust (CMFT) provide child and adolescent mental health services (CAMHS) for Manchester and Salford. The move towards Integrated Access andRead more

    • Coordinate My Care Integrates Care Plans into Emis Web

      By admin | Comments are Closed

      Urgent care plans for thousands of London’s most vulnerable patients care are now just a click away for almost 1,000 of their GPs. Plan sharing scheme Coordinate my Care will now be available to 962Read more

    • OWise breast cancer app proven to be effective tool in cancer treatment process

      By admin | Comments are Closed

      Innovative patient support app shown in peer-reviewed medical journal to improve patient-doctor interactions and is recommended by 90% of patients and clinicians OWise breast cancer, the first mobile app to offer patients personalised medical supportRead more

    • OBH featured in TeleMedicine Magazine

      By admin | Comments are Closed

      Telemedicine Magazine included an article on Outcome Based Healthcare (OBH) in their series focusing on the growing trend of doctors getting involved with healthcare start-ups. Rupert, OBH CEO, explained that during his time as aRead more

    NextPrevious
    Contact Us
    nia@uclpartners.com
    @NHSAccelerator
    Newsletter Sign-Up
    Terms and Conditions | Privacy and Cookies
    NHS Innovation Accerlator
    Copyright 2017 NHS Innovation Accelerator
    • Menu
      • Latest
      • Case Studies
      • News and Events
      • Press and Media
      • FAQs (OLD)
      • Contact Us
    • Apply
    • Fellows and Innovations
      • Fellows
      • Innovations
    • Collaborate
    • Accelerator
      • Partners
      • What the NIA offers
      • Selection Process
      • Mentors
    NIA